[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.119.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1955

Reserpine in the Treatment of Neuropsychiatric, Neurological, and Related Clinical Problems.

Author Affiliations
 

Edited by Roy Waldo Miner. Price, not given. Pp. 280. The New York Academy of Sciences, 2 East 63rd St., New York 21, 1955.

AMA Arch Intern Med. 1955;96(3):434-435. doi:10.1001/archinte.1955.00250140156024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

"Reserpine in the Treatment of Neuropsychiatric, Neurological, and Related Clinical Problems" is the subject of the April 15, 1955, issue of the Annals of the New York Academy of Sciences. Thirty papers describe the neuropharmacology and clinical uses of the drug. Two of the papers report the use of chloropromazine as well as the use of reserpine. The papers were the result of a conference on reserpine held by the Section of Biology of the New York Academy of Sciences on Feb. 3 and 4, 1955. Included are reports on the use of reserpine in the various psychoses and neuroses, ambulatory and hospitalized geriatric psychotics, essential hypertension, chronic schizophrenic reactions, shock-reversible and shock-resistent patients, chronically disturbed psychotic patients; irritable and hypertonic infants; office and private psychiatric practice; organic convulsive states, enuresis, and head injuries; epilepsy and behavior problems in children; narcotic withdrawal sickness; dermatological therapy; preoperative, peroperative, and postoperative sedation;

First Page Preview View Large
First page PDF preview
First page PDF preview
×